Screening

Breast cancer screening

INESSS September 2025 upgrade recall before expanding 45–49, not operational.

Screening

  • MSSS Ministère de la Santé et des Services sociaux
  • INSPQ Institut national de santé publique du Québec
  • CTFPHC Canadian Task Force on Preventive Health Care
DecisionGuideline
Who
Differs
RAMQ 50–74, no personal breast cancer
  • Invitation letter is the prescription.
  • If no letter, CCSR or MD/IPS prescription.
  • Invitations to 70–74 since January 2024.

PQDCS opens in a new tabEligibility opens in a new tabQuebec.ca opens in a new tabINSPQ PQDCS evaluation opens in a new tab

50–74, not systematic 40–49
  • 2024 draft never finalized.
  • Ontario self-referral from 40.

CMAJ 2018 opens in a new tabArchived 2024 opens in a new tabOntario opens in a new tab

Under 50 and over 74

No invitation
  • INESSS Institut national d'excellence en santé et services sociaux
  • CTFPHC Canadian Task Force on Preventive Health Care
DecisionGuideline
<50 or >74
DiffersOutside PQDCS invitations
No invitation
  • Discuss.
  • Prescribe if she chooses.
  • Do not promise a 40–49 invitation program.
  • INESSS September 2025 upgrade recall before expanding 45–49, not operational.

INESSS HTML opens in a new tabINESSS PDF opens in a new tabPQDCS

Not systematic 40–49 2024 draft never finalized.

CMAJ 2018

Higher risk

No high-risk MRI stream
  • MSSS Ministère de la Santé et des Services sociaux
DecisionGuideline
Higher risk
No Québec high-risk MRI stream
  • Genetics or specialized clinic.
  • May prescribe annual mammography inside 50–74, still in PQDCS.
  • No equivalent to Ontario High Risk OBSP.

Ontario High Risk OBSP (comparison only) opens in a new tabPQDCS

Reviewed 24 August 2026 against the official sources below.

Sources